Standex International Corporation Common Stock (SXI) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.
SXI has 4 Form 4 insider filings recorded at the SEC in the past 30 days[1].
Sources
- SEC EDGAR · 0000310354 (2026-04-11) ↗